Neo Ivy Capital Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-15,596
Closed -$2.1M – 473
2025
Q1
$2.1M Sell
15,596
-6,373
-29% -$839K 0.67% 55
2024
Q4
$2.77M Buy
+21,969
New +$3.27M 0.56% 73
2024
Q3
– Sell
-6,092
Closed -$810K – 391
2024
Q2
$810K Buy
+6,092
New +$733K 0.16% 148
2023
Q4
– Sell
-2,356
Closed -$155K – 444
2023
Q3
$155K Buy
+2,356
New +$176K 0.07% 242
2022
Q3
– Sell
-31
Closed -$1K – 545
2022
Q2
$1K Buy
+31
New +$2.16K ﹤0.01% 377
2021
Q4
– Sell
-1,980
Closed -$36K – 626
2021
Q3
$36K Buy
+1,980
New +$140K 0.04% 356
2020
Q4
– Sell
-120
Closed -$2K – 572
2020
Q3
$2K Sell
120
-1,860
-94% -$47.5K ﹤0.01% 442
2020
Q2
$36K Buy
+1,980
New +$39K 0.04% 356

Other funds holding THC

Neo Ivy Capital Management's THC Position: Q2 2025 in Review

Neo Ivy Capital Management sold out of Tenet Healthcare (THC) in Q2 2025, closing a stake of 15,596 shares — an estimated $2.1M sold.

Neo Ivy Capital Management first reported a position in THC in Q2 2020 and held it in 8 quarters. The position peaked at $2.77M in Q4 2024. 626 funds tracked by Wall St. Rank hold THC as of Q2 2025.

  • Neo Ivy Capital Management reported no remaining Tenet Healthcare position as of Q2 2025 after selling out during the quarter.
  • Neo Ivy Capital Management sold 15,596 Tenet Healthcare shares in Q2 2025, an estimated $2.1M.
  • Neo Ivy Capital Management first reported a position in Tenet Healthcare in Q2 2020 and held it in 8 quarters.
  • Neo Ivy Capital Management's Tenet Healthcare position peaked at $2.77M in Q4 2024.
  • 626 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2025.

Based on Neo Ivy Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.